Shiyovich, Arthur
Huck, Daniel M.
Cardoso, Rhanderson
Berman, Adam N.
Besser, Stephanie A.
Biery, David W.
Petranovic, Milena
Weber, Brittany N.
Hainer, Jon
Blair, Camila V.
Meyersohn, Nandini M.
Singh, Avinainder
Baliyan, Vinit
Lu, Michael T.
Steigner, Michael
Aghayev, Ayaz
Nasir, Khurram
Cannon, Christopher P.
Hedgire, Sandeep
Di Carli, Marcelo
Ghoshhajra, Brian
Blankstein, Ron
Article History
Received: 3 February 2026
Accepted: 14 April 2026
First Online: 15 June 2026
Declarations
:
: AS: consultant: Artrya Inc., Pfizer. MP: received fellowship funding from Novartis 2022-2024AA: WCG Clinical ConsultantBG: Research support to institution: Siemens. Consultant: 3DR Laboratories, Inc.AB: Dr. Berman is supported by the Robert A. Winn Excellence in Clinical Trials Career Development Award and the Glorney-Raisbeck Junior Faculty Research Award in Cardiovascular Diseases from the New York Academy of MedicineKN: Advisory Board Novartis, Amgen, Novo Nordisk, Esperion Consultant Corsera Health Research Funding: NIH, PCORI, IonisDMH is supported by an American Heart Association Career Development Award (23CDA1037589) and NIH/NHLBI K23 Career Development Award (HL171893).CC: Dr. Cannon reports in calendar years 2023 to 2025: Research Grants from: Amgen, Better Therapeutics, Boehringer-Ingelheim (BI), Novo Nordisk, and salary support from Colorado Prevention Center (CPC) Clinical Research, which gets research grant support from Amgen, Bayer, Cleerly, Esperion, Lexicon, Silence. Consulting fees from Amryt/Chiesi, Amgen, Applied Therapeutics, BI, BMS, CSL Behring, Genomadix, Lilly, Janssen, Milestone, Novartis, Pfizer, Rhoshan, TremeauI serve on Data and Safety Monitoring Boards for the Areteia, Cortera, Novartis, Novo Nordisk, ROMTherapy, Inc. and the Veterans Administration.MTL: Dr Lu has received research support to his institution from the American Heart Association, AstraZeneca, Ionis, Johnson & Johnson Innovation, Kowa, MedImmune, the National Academy of Medicine, the NIH/NHLBI, and the Risk Management Foundation of the Harvard Medical Institutions Incorporated outside of the submitted work. He reports serving on an advisory board for Eli Lilly.BW: Consulting/advisory for Novo Nordisk, Cleerly. Funding: BW K23HL159276 and THR Texas Health ScholarRB: Dr Blankstein has received research support from Amgen Inc, Novartis Inc, Heartflow Inc, and Nanox AI; and has served as a consultant for Caristo Inc, Heartflow Inc, Novartis Inc, and Nanox AI. MDC: Institutional research grants: Sun Pharma, Xylocor, Amgen, GE Healthcare, Gilead Sciences, Intellia Therapeutics. Consulting fees: GE Healthcare, MedTrace, Bitterroot Bio, Valo Health, Sofie